Patents by Inventor John S. Missanelli

John S. Missanelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414138
    Abstract: During childbirth process, trauma to an infant can readily arise, ultimately resulting in fetal hypoxia, academia, and brain damage. Such unfavorable conditions can be prevented by measuring the fetus' blood-oxygen level and heart rate. Without a fetal pulse oximeters, blood oxygen level cannot be monitored non-invasively reliably, which reduces the chance for birth complications to be recognized in time. A noninvasive system to implement such goals and maximize the potential welfare of the fetus may include devices to measure oxygen saturation of hemoglobin (SpO2). Such a device may be an oxy probe that uses a trans-reflective method of SpO2 measurement where oxygen saturation data can be transmitted through wire, fiber optics, and or using a radio frequency link, fetal monitor data can be analyzed, compared to existing data base, and or transmitted via radio waves or internet.
    Type: Application
    Filed: June 27, 2023
    Publication date: December 28, 2023
    Applicant: Heralife Medical, Inc.
    Inventors: John S. Missanelli, Vijay K. Lumba, Angela K. Lumba, Megan Missanelli
  • Publication number: 20230320634
    Abstract: During childbirth process, trauma to an infant can readily arise, ultimately resulting in fetal hypoxia, academia, and brain damage. Such unfavorable conditions can be prevented by measuring the fetus' blood-oxygen level and heart rate. Without a fetal pulse oximeters, blood oxygen level cannot be monitored non-invasively reliably, which reduces the chance for birth complications to be recognized in time. A noninvasive system to implement such goals and maximize the potential welfare of the fetus may include devices to measure oxygen saturation of hemoglobin (SpO2) that have been available for at least 50 years. Such a device may be an oxy probe that uses a trans-reflective method of SpO2 measurement where oxygen saturation data can be transmitted through wire, fiber optics, and or using a radio frequency link, fetal monitor data can be analyzed, compared to existing data base, and or transmitted via radio waves or internet.
    Type: Application
    Filed: April 11, 2023
    Publication date: October 12, 2023
    Applicant: Heralife Medical, Inc.
    Inventors: John S. Missanelli, Vijay K. Lumba, Angela K. Lumba, Megan Missanelli
  • Publication number: 20200077929
    Abstract: During childbirth process, trauma to an infant can readily arise, ultimately resulting in fetal hypoxia, academia, and brain damage. Such unfavorable conditions can be prevented by measuring the fetus' blood-oxygen level and heart rate. Without a fetal pulse oximeters, blood oxygen level cannot be monitored non-invasively reliably, which reduces the chance for birth complications to be recognized in time. A noninvasive system to implement such goals and maximize the potential welfare of the fetus may include devices to measure oxygen saturation of hemoglobin (SpO2) that have been available for at least 50 years. Such a device may be an oxy probe that uses a trans-reflective method of SpO2 measurement where oxygen saturation data can be transmitted through wire, fiber optics, and or using a radio frequency link, fetal monitor data can be analyzed, compared to existing data base, and or transmitted via radio waves or internet.
    Type: Application
    Filed: August 14, 2019
    Publication date: March 12, 2020
    Applicant: ANGEM Devices, Inc
    Inventors: John S. Missanelli, Vijay K. Lumba, Angela K. Lumba, Megan Missanelli
  • Patent number: 5193542
    Abstract: An oximeter probe is introduced through the vaginal canal and applied to the scalp or other readily accessible part of the fetus while still in utero. The fetal oxygenation is monitored during the entire labor and delivery period to obtain instantaneous indications of any peripartum fetal distress. The probe comprises a clamping device which can be easily manipulated within the narrow confines of the partially dilated cervix.
    Type: Grant
    Filed: March 25, 1992
    Date of Patent: March 16, 1993
    Inventors: John S. Missanelli, Mearl Naponic
  • Patent number: D663422
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: July 10, 2012
    Assignee: First Pulse Medical, Inc.
    Inventor: John S. Missanelli